Product Information
NATAZIA 28 TABLET is a brand product labeled by Bayer HealthCare Pharmaceuticals Inc., priced at $8.4637 per EA under NDC 50419040903. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 6, 2010.
Manufacturer
Bayer HealthCare Pharmaceuticals Inc.NDC
50419040903
Classification
Brand
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
New Drug (NDA)
FDA Application
NDA022252FDA Approved
5/6/2010
On Market Since
5/6/2010
Price Statistics
The NADAC for NATAZIA 28 TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 157.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.4637 per EA |
|---|---|
| All-time high | $8.4888 (Dec 11, 2024) |
| All-time low | $3.2904 (Nov 28, 2013) |
| 52-week high | $8.4804 |
| 52-week low | $8.4636 |
| Median price | $7.5502 |
| Average price | $6.8901 |
| Largest weekly change | +9.9% (Feb 18, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the estradiol valerate and estradiol valerate/dienogest market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bayer HealthCare Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
estradiol valerate and estradiol valerate/dienogest market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NATAZIA 28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NATAZIA 28 TABLET, manufactured by Bayer HealthCare Pharmaceuticals Inc., is $8.4637 per EA (NDC 50419040903), effective Sep 30, 2026.
How has the price of NATAZIA 28 TABLET changed over time?
Over the history we have for it, the NADAC for NATAZIA 28 TABLET has risen 157.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NATAZIA 28 TABLET?
Since Nov 28, 2013, the NADAC for NATAZIA 28 TABLET has ranged from a low of $3.2904 (Nov 28, 2013) to a high of $8.4888 (Dec 11, 2024), with a median of $7.5502 per EA.
Are there cheaper alternatives to NATAZIA 28 TABLET?
No other NADAC-published product currently shares the active ingredient and strength of NATAZIA 28 TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NATAZIA 28 TABLET?
NATAZIA 28 TABLET (NDC 50419040903) is labeled by Bayer HealthCare Pharmaceuticals Inc., and CMS classifies it as a brand product.